| # | Drug | Count |
|---|---|---|
| 0 | LEVONORGESTREL | 61 |
| 1 | COPPER | 24 |
| 2 | ERGOCALCIFEROL | 8 |
| 3 | METHOTREXATE | 7 |
| 4 | METHOTREXATE SODIUM | 7 |
| 5 | ADALIMUMAB | 6 |
| 6 | ALENDRONATE SODIUM | 6 |
| 7 | ASPIRIN | 6 |
| 8 | ASPIRIN 325 MG | 6 |
| 9 | ASPIRIN 81 MG | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FENOPROFEN CALCIUM | 1 | 0.0204 |
| 1 | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0049 |
| 2 | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | 1 | 0.0032 |
| 3 | ESTRADIOL ACETATE | 1 | 0.0013 |
| 4 | FOLLITROPIN ALFA | 2 | 0.0010 |
| 5 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 2 | 0.0007 |
| 6 | SUMATRIPTAN SUCCINATE AND NAPROXEN SODIUM | 1 | 0.0007 |
| 7 | CEFACLOR | 1 | 0.0006 |
| 8 | COPPER | 24 | 0.0006 |
| 9 | DAPRODUSTAT | 1 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Copper-containing Intrauterine Device [EPC] | 24 | 0.0005 |
| 1 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 2 | Progestin Antagonist [EPC] | 2 | 0.0004 |
| 3 | Estrogen Agonist/Antagonist [EPC] | 1 | 0.0004 |
| 4 | Oxytocic [EPC] | 1 | 0.0003 |
| 5 | Provitamin D2 Compound [EPC] | 8 | 0.0003 |
| 6 | Antiseptic [EPC] | 1 | 0.0002 |
| 7 | Progestin [EPC] | 66 | 0.0002 |
| 8 | Chloride Channel Activator [EPC] | 2 | 0.0002 |
| 9 | Progesterone [EPC] | 4 | 0.0002 |